✦ LIBER ✦

Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials

✍ Scribed by Katlama, Christine; Clotet, Bonaventura; Mills, Anthony; Trottier, Benoit; Molina, Jean-Michel; Grinsztejn, Beatriz; Towner, William; Haubrich, Richard; Nijs, Steven; Vingerhoets, Johan; Woodfall, Brian; Witek, James

Book ID: 119991316
Publisher: International Medical Press
Year: 2010
Tongue: English
Weight: 228 KB
Volume: 15
Category: Article
ISSN: 1359-6535
DOI: 10.3851/imp1662

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN21 ECONOMICAL EVALUATION OF ETRAVIRIN

PIN21 ECONOMICAL EVALUATION OF ETRAVIRINE IN TREATMENT-EXPERIENCED HIV-1-INFECTED PATIENTS BASED ON DUET TRIALS

✍ M Avxentyeva; P Vorobyev 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Efficacy and safety of TMC125 (etravirin

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

✍ José Valdez Madruga; Pedro Cahn; Beatriz Grinsztejn; Richard Haubrich; Jacob Lal 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB

Efficacy and safety of TMC125 (etravirin

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

✍ Adriano Lazzarin; Thomas Campbell; Bonaventura Clotet; Margaret Johnson; Christi 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB

Etravirine in treatment-experienced, HIV

Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study

✍ Tudor-Williams, G; Cahn, P; Chokephaibulkit, K; Fourie, J; Karatzios, C; Dincq, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

Efficacy and safety of darunavir-ritonav

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

✍ Bonaventura Clotet; Nicholas Bellos; Jean-Michel Molina; David Cooper; Jean-Chri 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 180 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of the Non-Nucleoside Reverse-Transcriptase Inhibitor Etravirine in Treatment-Experienced HIV-1-Infected Patients

✍ Kakuda, T N; Wade, J R; Snoeck, E; Vis, P; Schöller-Gyüre, M; Peeters, M P; Corb 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 991 KB